Clinical TrialsSearch results
Number of results: 386
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- CHOP therapy for low and low-intermediate risk patients of advanced aggressive non-Hodgkin's lymphoma (JCOG9508, LSG17(CHOP))
- low and low-intermediate risk of aggressive non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-09
Other
- Chronotherapy of methotrexate in patients with rheumatic arthritis
- rheumatoid arthritis
- Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama
- 2007-12-25
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery
(a randomized, double-blind, multi-center, placebo-controlled study)
- Colon cancer including RS cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Clinical evaluation of matrix metalloproteinases as early diagnostic markers of peritoneal deterioration and encapsulating peritoneal sclerosis.
- encapsulating peritoneal sclerosis (EPS)/ sclerosing encapsulating peritonitis(SEP)
- Division of Nephrology, Department of Medicine, Jichi Medical University
- 2013-04-30
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Completed
- Clinical study for alveolar ridge preservation using Cytrans Elashield
- Dental caries and/or periodontitis
- Ohba Seigo
- 2020-12-09
Completed
- Clinical study for guided bone regeneration using novel biodegradable membrane
- alveolar bone atrophy
- Asahina Izumi
- 2019-07-01
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group
- 2009-06-01
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-06-01
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04